关注
Lutz Preu
Lutz Preu
在 tu-braunschweig.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A
H Falke, A Chaikuad, A Becker, N Loaëc, O Lozach, S Abu Jhaisha, ...
Journal of medicinal chemistry 58 (7), 3131-3143, 2015
1182015
3,6-Diamino-4-(2-halophenyl)-2-benzoylthieno[2,3-b]pyridine-5-carbonitriles Are Selective Inhibitors of Plasmodium falciparum Glycogen Synthase Kinase-3
W Fugel, AE Oberholzer, B Gschloessl, R Dzikowski, N Pressburger, ...
Journal of medicinal chemistry 56 (1), 264-275, 2013
792013
Identification of 2-Anilino-9-methoxy-5,7-dihydro-6H-pyrimido[5,4-d][1]benzazepin-6-ones as Dual PLK1/VEGF-R2 Kinase Inhibitor Chemotypes by Structure …
AM Egert-Schmidt, J Dreher, U Dunkel, S Kohfeld, L Preu, H Weber, ...
Journal of medicinal chemistry 53 (6), 2433-2442, 2010
742010
Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3-thienyl) nicotinonitrile scaffold
W Brandt, L Mologni, L Preu, T Lemcke, C Gambacorti-Passerini, ...
European journal of medicinal chemistry 45 (7), 2919-2927, 2010
662010
Evaluation of monolithic HPLC columns for various pharmaceutical separations: Method transfer from conventional phases and batch to batch repeatability
S El Deeb, L Preu, H Wätzig
Journal of pharmaceutical and biomedical analysis 44 (1), 85-95, 2007
512007
2-Anilino-4-(benzimidazol-2-yl) pyrimidines–A multikinase inhibitor scaffold with antiproliferative activity toward cancer cell lines
R Determann, J Dreher, K Baumann, L Preu, PG Jones, F Totzke, ...
European journal of medicinal chemistry 53, 254-263, 2012
492012
Structural studies of organoboron compounds. XXIV. 5-Methyl-5-nitro-2-phenyl-1, 3-dioxa-2-boracyclohexane
W Kliegel, L Preu, SJ Rettig, J Trotter
Canadian journal of chemistry 64 (9), 1855-1858, 1986
401986
9-and 11-substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma
F Maiwald, D Benítez, D Charquero, MA Dar, H Erdmann, L Preu, O Koch, ...
European Journal of Medicinal Chemistry 83, 274-283, 2014
382014
Wide concentration range investigation of recovery, precision and error structure in liquid chromatography
U Schepers, J Ermer, L Preu, H Wätzig
Journal of Chromatography B 810 (1), 111-118, 2004
382004
Indole-3-carbonitriles as DYRK1A inhibitors by fragment-based drug design
R Meine, W Becker, H Falke, L Preu, N Loaëc, L Meijer, C Kunick
Molecules 23 (2), 64, 2018
342018
Development of 5-benzylpaullones and paullone-9-carboxylic acid alkyl esters as selective inhibitors of mitochondrial malate dehydrogenase (mMDH)
A Becker, S Kohfeld, A Lader, L Preu, T Pies, K Wieking, Y Ferandin, ...
European journal of medicinal chemistry 45 (1), 335-342, 2010
312010
Structural studies of organoboron compounds. XXI. Crystal and molecular structures of 3-(phenylmethylidene)-4-methyl-1-phenyl-2, 6, 7-trioxa-3-azonia-1-boratabicyclo-[2.2. 2 …
W Kliegel, L Preu, SJ Rettig, J Trotter
Canadian journal of chemistry 63 (2), 509-515, 1985
301985
2-Arylpaullones are selective antitrypanosomal agents
J Ryczak, M Papini, A Lader, A Nasereddin, D Kopelyanskiy, L Preu, ...
European Journal of Medicinal Chemistry 64, 396-400, 2013
292013
A strategy to develop fast RP‐HPLC methods using monolithic silica columns
S El Deeb, L Preu, H Wätzig
Journal of separation science 30 (13), 1993-2001, 2007
292007
Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines
A Masch, A Nasereddin, A Alder, MJ Bird, SI Schweda, L Preu, C Doerig, ...
Malaria journal 18, 1-10, 2019
282019
Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype
A Walter, A Chaikuad, R Helmer, N Loaëc, L Preu, I Ott, S Knapp, L Meijer, ...
PLoS One 13 (5), e0196761, 2018
252018
5-Substituted 3-chlorokenpaullone derivatives are potent inhibitors of Trypanosoma brucei bloodstream forms
OCF Orban, RS Korn, D Benítez, A Medeiros, L Preu, N Loaëc, L Meijer, ...
Bioorganic & Medicinal Chemistry 24 (16), 3790-3800, 2016
252016
Dimroth‐Umlagerung von Iminen des 1, 5‐Diaminotetrazols
D Moderhack, KH Goos, L Preu
Chemische Berichte 123 (7), 1575-1578, 1990
251990
Parenteral formulation of an antileishmanial drug candidate–Tackling poor solubility, chemical instability, and polymorphism
E Kupetz, L Preu, C Kunick, H Bunjes
European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 511-520, 2013
192013
Separation of cold medicine ingredients using a precise MEKC method at elevated pH
P Hasemann, M ter Balk, L Preu, H Wätzig
Electrophoresis 28 (11), 1779-1787, 2007
182007
系统目前无法执行此操作,请稍后再试。
文章 1–20